AHA to HRSA: Implement 340B Drug Ceiling Price Rule Without Further Delay

AHA comments to HRSA regarding proposed rule that would further delay the effective date for implementing final regulations regarding the 340B Drug Pricing Program ceiling price and drug manufacturers’ civil monetary penalties (CMPs) for violations of the ceiling price.

Related Resources

Special Bulletin
Member
The Centers for Medicare & Medicaid Services (CMS) July 10 issued a proposed rule that would establish a new alternative payment model (APM) fo
Special Bulletin
Member
The Centers for Medicare & Medicaid Services’ (CMS) Center for Medicare and Medicaid Innovation (CMMI) July 10 announced five new CMMI payment
Press Releases
Special Bulletin
Member
The White House June 24 released an executive order on “improving price and quality transparency in American health care.” The executive order focu
Action Alert
Member
The Senate Committee on Health, Education, Labor and Pensions has released the Lower Health Care Costs Act of 2019 – bipartisan discussion draft legislation to…
Letter/Comment
Public
AHA's comment on HHS' Office of the National Coordinator for Health Information Technology’s proposed rule on interoperability, information blocking and the…